Teriflunomide Tablet, Film Coated
NDC Package 70710-1114-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Teriflunomide tablets is a medication used to treat multiple sclerosis-MS. This formulation utilizes a tablet, film coated delivery system. Marketed by Zydus Pharmaceuticals Usa Inc., this product is identified by NDC 70710-1114 and is authorized under FDA application ANDA209668.

Identification & Billing

NDC Package Code
70710-1114-3
Package Description
30 TABLET, FILM COATED in 1 BOTTLE
Product Code
70710-1114
11-Digit Billing Format
70710111403
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Teriflunomide
Non-Proprietary Name
Teriflunomide
Substance Name
Teriflunomide
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
TERIFLUNOMIDE 7 mg/1
Pharmacologic Class
Usage Information
This medication is used to treat multiple sclerosis-MS. It is not a cure for MS but is thought to work by decreasing certain immune system cells (lymphocytes) which can attack the nerves in your brain and spinal cord. This helps decrease the number of flare-ups (relapses) and may help slow down physical problems caused by MS.

Regulatory & Marketing

Labeler Name
Zydus Pharmaceuticals Usa Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA209668
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-14-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70710-1114). Click a package code to view its specific billing and regulatory data.

70710-1114-8
2 CARTON in 1 CARTON / 1 BLISTER PACK in 1 CARTON (70710-1114-7) / 14 TABLET, FILM COATED in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70710-1114-3 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Teriflunomide, a human prescription drug labeled by Zydus Pharmaceuticals Usa Inc.. This tablet, film coated is formulated for oral use and contains teriflunomide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Pharmaceuticals Usa Inc. on February 14, 2023. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used to treat multiple sclerosis-MS. It is not a cure for MS but is thought to work by decreasing certain immune system cells (lymphocytes) which can attack the nerves in your brain and spinal cord. This helps decrease the number of flare-ups (relapses) and may help slow down physical problems caused by MS.

How is this Zydus Pharmaceuticals Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70710111403. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70710-1114-3
11-Digit CMS (5-4-2)
70710-1114-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.